Cancer therapeutics is an area of constant innovation. Historically, cancer treatments have been a very invasive and detrimental process to the body. Now, there are numerous new techniques now available for those with cancer that are not as invasive and detrimental to the body as a whole. The most common cancers affecting the world population include lung, breast, colon/rectum, stomach, liver, prostate, cervical, esophageal, and bladder. The mainstay of systemic therapy for solid and hematological malignancies in the 20th century was chemotherapy. This approach has drawbacks including toxicity to normal tissue, drug resistance and lack of efficacy. The demand for more effective and tolerable treatments has led to the development of novel therapeutic agents that specifically target the malignant cells. Increasingly, immunological treatments are taking center stage. These reports offer market sizing, estimates, forecasts and trend information for cancer treatments.
- Instrument Launches, Small-Molecule Techniques and Kool-Aid as PITTCON Philadelphia Begins March 18, 2019
- What Does The “Second Wave” of 2018/19 Flu Season Mean for IVD Markets? March 12, 2019
- New Report Details $350 Billion Industry That No One Dominates February 28, 2019
- Innovations in Microbiology Testing February 25, 2019
- VA – Foundation Medicine Deal a Boon for Use of Liquid Biopsy/NGS in Cancer Diagnostics February 15, 2019
For more than 30 years, Kalorama Information has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.